相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy-induced colitis
Toshiharu Sakurai et al.
MOLECULAR ONCOLOGY (2022)
Human gut bacteria produce TH17-modulating bile acid metabolites
Donggi Paik et al.
NATURE (2022)
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
John A. McCulloch et al.
NATURE MEDICINE (2022)
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy
Jahan J. Mohiuddin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Gut microbiota-derived metabolites as central regulators in metabolic disorders
Allison Agus et al.
GUT (2021)
Bacteroides thetaiotaomicron relieves colon inflammation by activating aryl hydrocarbon receptor and modulating CD4+T cell homeostasis
Keying Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Interferon-Gamma-Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis
Sarah C. Sasson et al.
GASTROENTEROLOGY (2021)
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch et al.
SCIENCE (2021)
Intestinal flora characteristics of advanced non-small cell lung cancer in China and their role in chemotherapy based on metagenomics: A prospective exploratory cohort study
Min Zhang et al.
THORACIC CANCER (2021)
Optotheranostic Nanosystem with Phone Visual Diagnosis and Optogenetic Microbial Therapy for Ulcerative Colitis At-Home Care
Meihui Cui et al.
ACS NANO (2021)
Bacteroides ovatus Promotes IL-22 Production and Reduces Trinitrobenzene Sulfonic Acid-Driven Colonic Inflammation
Faith D. Ihekweazu et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management
Liansha Tang et al.
FRONTIERS IN IMMUNOLOGY (2021)
An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae/butyrate/retinoic acid axis
Lifu Wang et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)
Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis
Xu Yan et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease
Angela Saez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Immune Checkpoint Inhibitor-associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies
Ashley N. Tran et al.
JOURNAL OF IMMUNOTHERAPY (2021)
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Miles C. Andrews et al.
NATURE MEDICINE (2021)
Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8+T cells and an infiltration pattern that resembles ulcerative colitis
Sara Hone Lopez et al.
VIRCHOWS ARCHIV (2021)
Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation
Xin Wen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
High-dose corticosteroid use and risk of hospitalization for infection in patients treated with immune checkpoint inhibitors--A nationwide register-based cohort study
Signe Sorup et al.
CANCER MEDICINE (2021)
The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy
Xiangjun Liu et al.
FRONTIERS IN ONCOLOGY (2021)
B. adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling
Lina Fan et al.
GUT MICROBES (2021)
Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: A therapeutic target to control intestinal inflammation
Jie Zhang et al.
MEDICINAL RESEARCH REVIEWS (2021)
Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer
Hiroaki Akamatsu et al.
ONCOLOGIST (2020)
Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment Registry
Rik J. Verheijden et al.
CLINICAL CANCER RESEARCH (2020)
Depletion of Foxp3+ regulatory T cells is accompanied by an increase in the relative abundance of Firmicutes in the murine gut microbiome
Jan Kehrmann et al.
IMMUNOLOGY (2020)
Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration
Giovanni Sorrentino et al.
GASTROENTEROLOGY (2020)
A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice
Lijuan Wang et al.
GUT (2020)
Truncation of CXCL8 to CXCL8(9-77) enhances actin polymerization and in vivo migration of neutrophils
Mieke Metzemaekers et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
Clarissa Campbell et al.
NATURE (2020)
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis
S. C. Sasson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis
Shilpa Grover et al.
CANCER (2020)
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
Adrienne M. Luoma et al.
CELL (2020)
The Immune Modulating Properties of Mucosal-Associated Invariant T Cells
Melina Ioannidis et al.
FRONTIERS IN IMMUNOLOGY (2020)
Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor
Samantha A. Scott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti-PD-1 Immune Checkpoint Inhibitors
Nicholas J. Salgia et al.
EUROPEAN UROLOGY (2020)
Indoles from the commensal microbiota act via the AHR and IL-10 to tune the cellular composition of the colonic epithelium during aging
Domonica N. Powell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade
Shan Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Mechanisms and microbial influences on CTLA-4 and PD-1-based immunotherapy in the treatment of cancer: a narrative review
Peter L. Miller et al.
GUT PATHOGENS (2020)
The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer
Taiki Hakozaki et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Management of Immune Checkpoint Inhibitor Toxicities
Quentin Durrechou et al.
Cancer Management and Research (2020)
In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of Parabacteroides distasonis Strains Alleviating TNBS-Induced Colitis in Mice
Bernardo Cuffaro et al.
CELLS (2020)
How to manage patients with corticosteroids in oncology in the era of immunotherapy?
Mihaela Aldea et al.
EUROPEAN JOURNAL OF CANCER (2020)
The gut microbiome can be used to predict the gastrointestinal response and efficacy of lung cancer patients undergoing chemotherapy
Min Zhang et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Prevotella Induces the Production of Th17 Cells in the Colon of Mice
Yuan Huang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Takeshi Tanoue et al.
NATURE (2019)
The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management
Jane Fletcher et al.
NUTRIENTS (2019)
Alleviation of Intestinal Inflammation by Oral Supplementation With 2-Fucosyllactose in Mice
Thomas Grabinger et al.
FRONTIERS IN MICROBIOLOGY (2019)
Probiotics Lactobacillus reuteri Abrogates Immune Checkpoint Blockade-Associated Colitis by Inhibiting Group 3 Innate Lymphoid Cells
Tingting Wang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota
You Jin Jang et al.
GUT MICROBES (2019)
C-reactive protein as an early marker of immune-related adverse events
Amir-Reza Abolhassani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
Maria Pia Pistillo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors
Omar Hasan Ali et al.
EUROPEAN JOURNAL OF CANCER (2019)
Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A
June L. Chan et al.
MUCOSAL IMMUNOLOGY (2019)
Diet modulates colonic T cell responses by regulating the expression of a Bacteroides thetaiotaomicron antigen
Marta M. Wegorzewska et al.
SCIENCE IMMUNOLOGY (2019)
Bacteroidales recruit IL-6-producing intraepithelial lymphocytes in the colon to promote barrier integrity
K. A. Kuhn et al.
MUCOSAL IMMUNOLOGY (2018)
Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo
M. Jennis et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Kristian M. Hargadon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
The Risk of Diarrhea and Colitis in Patients With Advanced Melanoma Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis
Parul Tandon et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Lactobacillus acidophilus Improves Intestinal Inflammation in an Acute Colitis Mouse Model by Regulation of Th17 and Treg Cell Balance and Fibrosis Development
Jin-Sil Park et al.
JOURNAL OF MEDICINAL FOOD (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Lactobacillus acidophilus and Clostridium butyricum ameliorate colitis in murine by strengthening the gut barrier function and decreasing inflammatory factors
Y. Wang et al.
BENEFICIAL MICROBES (2018)
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages
Smitha Krishnan et al.
CELL REPORTS (2018)
Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma
Takayuki Nakayama et al.
CLINICAL GENITOURINARY CANCER (2018)
Enterocolitis due to immune checkpoint inhibitors: a systematic review
Emilie Soularue et al.
GUT (2018)
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang et al.
NATURE MEDICINE (2018)
Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management
Marnix H. Geukes Foppen et al.
ESMO OPEN (2018)
Fecal microbiota transplant - a new frontier in inflammatory bowel disease
Tagore Sunkara et al.
JOURNAL OF INFLAMMATION RESEARCH (2018)
Upregulation of bacterial-specific Th1 and Th17 responses that are enriched in CXCR5+ CD4+ T cells in non-small cell lung cancer
Qin-Yun Ma et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities
Clelia Coutzac et al.
JOURNAL OF CROHNS & COLITIS (2017)
Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicity
Alessandro Inno et al.
TUMORI JOURNAL (2017)
Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicity
Alessandro Inno et al.
TUMORI JOURNAL (2017)
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review
J. Bradford Rice et al.
CLINICAL THERAPEUTICS (2017)
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review
L. Khoja et al.
ANNALS OF ONCOLOGY (2017)
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
N. Chaput et al.
ANNALS OF ONCOLOGY (2017)
Interleukin 17 is a chief orchestrator of immunity
Marc Veldhoen
NATURE IMMUNOLOGY (2017)
Manipulation of the gut microbiota using resistant starch is associated with protection against colitis-associated colorectal cancer in rats
Ying Hu et al.
CARCINOGENESIS (2016)
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Annika Wahlstrom et al.
CELL METABOLISM (2016)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
Krista Dubin et al.
NATURE COMMUNICATIONS (2016)
A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints
Yongshu Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Systematic review: colitis associated with anti-CTLA-4 therapy
A. Gupta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer
Lavinia Nardinocchi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
Emanuela Romano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms
Gang Xiao et al.
ONCOTARGET (2015)
The effect of short-chain fatty acids on human monocyte-derived dendritic cells
Claudia Nastasi et al.
SCIENTIFIC REPORTS (2015)
Plasmacytoid Dendritic Cells Mediate Anti-inflammatory Responses to a Gut Commensal Molecule via Both Innate and Adaptive Mechanisms
Suryasarathi Dasgupta et al.
CELL HOST & MICROBE (2014)
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
Nagendra Singh et al.
IMMUNITY (2014)
Human Gut Dendritic Cells Drive Aberrant Gut-specific T-cell Responses in Ulcerative Colitis, Characterized by Increased IL-4 Production and Loss of IL-22 and IFNγ
Elizabeth R. Mann et al.
INFLAMMATORY BOWEL DISEASES (2014)
The Role of CXCR3 in DSS-Induced Colitis
Belal Chami et al.
PLOS ONE (2014)
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
Pamela V. Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Monocolonization of Germ-Free Mice with Bacteroides fragilis Protects against Dextran Sulfate Sodium-Induced Acute Colitis
Chien-Chao Chiu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Yukihiro Furusawa et al.
NATURE (2013)
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis
Patrick M. Smith et al.
SCIENCE (2013)
IL-17 and TNF-α Sustain Neutrophil Recruitment during Inflammation through Synergistic Effects on Endothelial Activation
Gabriel K. Griffin et al.
JOURNAL OF IMMUNOLOGY (2012)
Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation
Ashutosh Chaudhry et al.
IMMUNITY (2011)
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
Omar S. Qureshi et al.
SCIENCE (2011)
Beneficial effects of Bacteroides fragilis polysaccharides on the immune system
Erin B. Troy et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
Th17 Cytokines and the Gut Mucosal Barrier
Christoph Blaschitz et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
A human gut microbial gene catalogue established by metagenomic sequencing
Junjie Qin et al.
NATURE (2010)
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota
June L. Round et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Kendle M. Maslowski et al.
NATURE (2009)
α-CTLA-4 mAb-associated panenteritis -: A histologic and immunohistochemical analysis
Darryl A. Oble et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
Generation of gut-homing T cells and their localization to the small intestinal mucosa
Bengt Johansson-Lindbom et al.
IMMUNOLOGICAL REVIEWS (2007)
Colonic health: Fermentation and short chain fatty acids
JMW Wong et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
分享论文
